Suppr超能文献

PKM前体mRNA广泛剪接调控中错配识别的热力学控制

Thermodynamic control of mismatch discrimination for extensive splicing regulation of PKM pre-mRNA.

作者信息

Bartyś Natalia, Lisowiec-Wąchnicka Jolanta, Pasternak Anna

机构信息

Department of Nucleic Acids Bioengineering, Institute of Bioorganic Chemistry, Polish Academy of Sciences, 61-704 Poznan, Poland

Department of Nucleic Acids Bioengineering, Institute of Bioorganic Chemistry, Polish Academy of Sciences, 61-704 Poznan, Poland.

出版信息

RNA. 2025 Mar 18;31(4):475-485. doi: 10.1261/rna.080212.124.

Abstract

In this article, we present an approach to maximizing the splicing regulatory properties of splice-switching oligonucleotide (SSO) designed to regulate alternative splicing of pyruvate kinase M ( pre-mRNA. The studied SSO interacts with the regulatory element in exon 10 of pre-mRNA and contributes to a significant reduction of PKM2 level with a simultaneous increase of the PKM1 isoform. This SSO forms a duplex not only with the regulatory fragment of exon 10 but also with a similar RNA fragment of intron 9. The impact of this unspecific interaction on SSO regulatory properties, as well as the functional role of the intron 9 fragment, remains debatable. Herein, two types of modified nucleotides, unlocked nucleic acids (UNAs) and locked nucleic acids (LNAs), were used to study mismatch discrimination within duplexes involving modified SSOs. Our studies showed that LNAs increased mismatch discrimination, resulting in stronger regulatory properties of SSO. On the other hand, UNA reduced mismatch discrimination, decreasing the potentially therapeutic properties of SSO. The results indicate that specific interactions with exon 10 are more favorable for therapeutic applications than simultaneous hybridization with intron 9 and exon 10. The results also suggest the lack of a regulatory role for the intron 9 target site in alternative splicing of PKM pre-mRNA.

摘要

在本文中,我们提出了一种方法,用于最大化旨在调节丙酮酸激酶M(PKM)前体mRNA可变剪接的剪接转换寡核苷酸(SSO)的剪接调控特性。所研究的SSO与PKM前体mRNA外显子10中的调控元件相互作用,可显著降低PKM2水平,同时增加PKM1异构体的水平。该SSO不仅与外显子10的调控片段形成双链体,还与内含子9的类似RNA片段形成双链体。这种非特异性相互作用对SSO调控特性的影响以及内含子9片段的功能作用仍存在争议。在此,使用了两种类型的修饰核苷酸,即解锁核酸(UNA)和锁核酸(LNA),来研究涉及修饰SSO的双链体内的错配识别。我们的研究表明,LNA增加了错配识别,从而增强了SSO的调控特性。另一方面,UNA降低了错配识别,降低了SSO的潜在治疗特性。结果表明,与外显子10的特异性相互作用比与内含子9和外显子10同时杂交更有利于治疗应用。结果还表明内含子9靶位点在PKM前体mRNA可变剪接中缺乏调控作用。

相似文献

2
Functional analysis of the zinc finger modules of the splicing factor Luc7.
RNA. 2024 Jul 16;30(8):1058-1069. doi: 10.1261/rna.079956.124.
3
Positioning of pyrimidine motifs around cassette exons defines their PTB-dependent splicing in Arabidopsis.
Plant J. 2024 Jun;118(6):2202-2218. doi: 10.1111/tpj.16739. Epub 2024 Apr 5.
5
hnRNP A1 induces aberrant exon 9 splicing via a newly discovered ESS element.
Life Sci Alliance. 2025 Jun 16;8(9). doi: 10.26508/lsa.202402720. Print 2025 Sep.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.

本文引用的文献

1
Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases.
BioDrugs. 2024 Mar;38(2):177-203. doi: 10.1007/s40259-024-00644-7. Epub 2024 Jan 22.
3
Chemistry, structure and function of approved oligonucleotide therapeutics.
Nucleic Acids Res. 2023 Apr 11;51(6):2529-2573. doi: 10.1093/nar/gkad067.
4
ASO-Based PKM Splice-Switching Therapy Inhibits Hepatocellular Carcinoma Growth.
Cancer Res. 2022 Mar 1;82(5):900-915. doi: 10.1158/0008-5472.CAN-20-0948.
5
Splice-Switching Antisense Oligonucleotides as a Targeted Intrinsic Engineering Tool for Generating Armored Redirected T Cells.
Nucleic Acid Ther. 2021 Apr;31(2):145-154. doi: 10.1089/nat.2020.0905. Epub 2021 Feb 9.
6
Hybridization-mediated off-target effects of splice-switching antisense oligonucleotides.
Nucleic Acids Res. 2020 Jan 24;48(2):802-816. doi: 10.1093/nar/gkz1132.
7
Evaluation of off-target effects of gapmer antisense oligonucleotides using human cells.
Genes Cells. 2019 Dec;24(12):827-835. doi: 10.1111/gtc.12730. Epub 2019 Nov 12.
9
Nusinersen for the treatment of spinal muscular atrophy.
Expert Rev Neurother. 2017 Oct;17(10):955-962. doi: 10.1080/14737175.2017.1364159. Epub 2017 Sep 8.
10
Splice-switching antisense oligonucleotides as therapeutic drugs.
Nucleic Acids Res. 2016 Aug 19;44(14):6549-63. doi: 10.1093/nar/gkw533. Epub 2016 Jun 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验